Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Biliary Tract Neoplasms 3Breast Neoplasms 2Uterine Neoplasms 1Sarcoma, Ewing 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1

Interventions

Temozolomide 7Vincristine 5X-Rays 4Specimen Handling 4Phantoms, Imaging 4Magnetic Resonance Spectroscopy 4Irinotecan 4Cyclophosphamide 4cabozantinib 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2liposomal doxorubicin 2ivosidenib 2Topotecan 2Radiation 2Nuclear Medicine Department, Hospital 2LY3023414 2Eflornithine 2Congresses as Topic 2trifluridine tipiracil drug combination 1talazoparib 1silmitasertib 1romiplostim 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Liquid Biopsy × 90 days × Clear all
NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡